INS and early-onset autosomal dominant Alzheimer disease: Intranasal (IN) insulin has been shown to improve memory in healthy humans and in a clinical trial to treat patients with Alzheimer’s disease, IN insulin improved cognitive function and preserved metabolic integrity13,14.